Unity Biotechnology, Inc.
Hedge Funds Holdings
Last updated:
Unity Biotechnology, Inc.‘s stocks are currently a part of 26 hedge funds’ portfolios, which represents 9.8% of the total amount of its stocks outstanding. This makes up a total of 930.58K shares of Unity Biotechnology, Inc.. Compared to the previous quarter, the number fell by -82.30% or -4.32M shares fewer. As for the holding position changes, 15.38% (4) of current hedge fund investors increased the number of shares held, 23.08% (6) of current holders sold a part of the shares held, and 42.31% (11) closed the holdings completely. 5 hedge funds are new holders of Unity Biotechnology, Inc. stock in Q1 2023, it is 19.23% of total holders.
Hedge funds holding Unity Biotechnology (Q2 2018 – Q1 2023)
| Q2 2018 | 41 |
|---|---|
| Q3 2018 | 41 |
| Q4 2018 | 53 |
| Q1 2019 | 54 |
| Q2 2019 | 54 |
| Q3 2019 | 61 |
| Q4 2019 | 77 |
| Q1 2020 | 71 |
| Q2 2020 | 81 |
| Q3 2020 | 77 |
| Q4 2020 | 78 |
| Q1 2021 | 85 |
| Q2 2021 | 89 |
| Q3 2021 | 74 |
| Q4 2021 | 62 |
| Q1 2022 | 58 |
| Q2 2022 | 53 |
| Q3 2022 | 58 |
| Q4 2022 | 51 |
| Q1 2023 | 26 |
Hedge funds changes in Unity Biotechnology positions (Q2 2018 – Q1 2023)
| Q2 2018 | 41 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q3 2018 | 7 | 20 | 4 | 7 | 3 |
| Q4 2018 | 19 | 21 | 6 | 7 | 0 |
| Q1 2019 | 12 | 23 | 11 | 11 | -3 |
| Q2 2019 | 12 | 23 | 9 | 8 | 2 |
| Q3 2019 | 11 | 19 | 18 | 4 | 9 |
| Q4 2019 | 21 | 34 | 10 | 5 | 7 |
| Q1 2020 | 9 | 22 | 23 | 14 | 3 |
| Q2 2020 | 21 | 30 | 14 | 11 | 5 |
| Q3 2020 | 19 | 22 | 22 | 22 | -8 |
| Q4 2020 | 16 | 35 | 11 | 15 | 1 |
| Q1 2021 | 15 | 20 | 27 | 8 | 15 |
| Q2 2021 | 27 | 16 | 23 | 23 | 0 |
| Q3 2021 | 6 | 17 | 29 | 19 | 3 |
| Q4 2021 | 13 | 20 | 12 | 24 | -7 |
| Q1 2022 | 9 | 13 | 18 | 13 | 5 |
| Q2 2022 | 11 | 14 | 16 | 16 | -4 |
| Q3 2022 | 24 | 15 | 7 | 19 | -7 |
| Q4 2022 | 48 | 1 | 1 | 55 | -54 |
| Q1 2023 | 5 | 4 | 6 | 11 | 0 |
Hedge funds changes in Unity Biotechnology stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 0 | 0 |
|---|---|---|
| Q3 2018 | 0 | 0 |
| Q4 2018 | 0 | 0 |
| Q1 2019 | 0 | 97,000 |
| Q2 2019 | 76,000 | 4,000 |
| Q3 2019 | 0 | 0 |
| Q4 2019 | 2,000 | 4,000 |
| Q1 2020 | 122,000 | 1,000 |
| Q2 2020 | 256,000 | 1,000 |
| Q3 2020 | 462,000 | 706,000 |
| Q4 2020 | 594,000 | 472,000 |
| Q1 2021 | 1,029,000 | 761,000 |
| Q2 2021 | 1,410,000 | 474,000 |
| Q3 2021 | 1,085,000 | 269,000 |
| Q4 2021 | 250,000 | 309,000 |
| Q1 2022 | 1,982,000 | 130,000 |
| Q2 2022 | 1,048,000 | 33,000 |
| Q3 2022 | 5,746,000 | 24,000 |
| Q4 2022 | 4,146,575 | 96,091 |
| Q1 2023 | 15,729,000 | 10,000 |